Emily's Entourage gibt die Aufnahme von David M. Bedwell, PhD, in seinen wissenschaftlichen Beirat bekannt

Dr. Bedwell joins seven other highly respected and experienced researchers, clinicians, and health industry leaders to provide guidance on strategic research priorities for the organization

David M. Bedwell, PhD, joins the Scientific Advisory Board for Emily’s Entourage

Lower Merion, PA — Sept. 12, 2022 — Emily’s Entourage (EE), an innovative 501(c)3 foundation that accelerates research for new treatments and a cure for the final 10% of people with cystic fibrosis (CF), including those with nonsense mutations, today announced the addition of David M. Bedwell, PhD, to its Scientific Advisory Board (SAB). EE’s SAB brings together top researchers, clinicians, and health industry leaders, including some of the most respected names in CF research and care.

Dr. Bedwell is the James C. and Elizabeth T. Lee Endowed Chair of Biochemistry and is professor and chair of the Department of Biochemistry and Molecular Genetics in the Heersink School of Medicine at the University of Alabama at Birmingham (UAB).

“Dr. Bedwell brings decades of expertise and leadership in key areas in cystic fibrosis research, as well as a palpable passion for the CF community at large,” said Chandra Ghose, PhD, Chief Scientific Officer at Emily’s Entourage. “We are thrilled to have him as an invaluable member of our SAB as we continue our work on expediting the research and development of therapeutics for patients with CF who do not benefit from current mutation-targeted treatments.”

Dr. Bedwell serves as the co-director of the UAB Structural Biology Program and as the interim director of the Gregory Fleming James Cystic Fibrosis Research Center. He is also an editorial board member for the Journal of Biological Chemistry. 

“I’m delighted to be given the opportunity to join the team at Emily’s Entourage,” said Dr. Bedwell. “I have been impressed with their past accomplishments and I hope I can help them achieve many more in the coming years.”

Dr. Bedwell sits on the Wissenschaftlicher Beirat alongside the following members:

• Jennifer Bomberger, PhD
• Kevin Foskett, PhD (Vorstandsvorsitzender)
• Denis Hadjiliadis, MD
• Batsheva Kerem, PhD
• Jennifer Taylor-Cousar, MD, MSCS, ATSF
• Ted J. Torphy, PhD
• David B. Weiner, PhD

###

Über Emily's Entourage
Emily's Entourage ist eine innovative 501(c)3-Stiftung, die die Forschung nach neuen Therapien und einer Heilung für Nonsense-Mutationen bei Mukoviszidose, einer tödlichen Erbkrankheit, die vor allem die Lunge und das Verdauungssystem betrifft, beschleunigt. Seit 2011 hat Emily's Entourage Forschungsgelder in Millionenhöhe vergeben, ein Gentherapieunternehmen für Mukoviszidose gegründet, ein Patientenregister und ein Programm zur Vermittlung von klinischen Studien entwickelt, um die Rekrutierung von Patienten für klinische Studien zu beschleunigen, und weltweite Anstrengungen unternommen, um die Forschung und Medikamentenentwicklung voranzutreiben. Über die Organisation wurde in den nationalen Medien berichtet, darunter in der New York Times, STAT, CNN, People und anderen. Erfahren Sie mehr unter emilysentourage.org. 

Medienkontakt
Ashling-Ritter
Direktor für Marketing und Kommunikation
Emily's Entourage
ashling@emilysentourage.org